Page 66 - சிகிச்சை ஆராய்ச்சி க்கு மேம்படுத்த அறிவாற்றல் இல் ஸ்கிசோஃப்ரினியா News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from சிகிச்சை ஆராய்ச்சி க்கு மேம்படுத்த அறிவாற்றல் இல் ஸ்கிசோஃப்ரினியா. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In சிகிச்சை ஆராய்ச்சி க்கு மேம்படுத்த அறிவாற்றல் இல் ஸ்கிசோஃப்ரினியா Today - Breaking & Trending Today

'Shameful and criminal': Long waiting lists for Otago cancer patients

Shameful and criminal : Long waiting lists for Otago cancer patients
3 May, 2021 05:58 PM
3 minutes to read
A person with a confirmed cancer diagnosis should be able to their first treatment within 31 days, which is not happening at the Southern District Health Board. Photo / Sarah Ivey, File
A person with a confirmed cancer diagnosis should be able to their first treatment within 31 days, which is not happening at the Southern District Health Board. Photo / Sarah Ivey, File
NZ Herald
By: Mike Houlahan
More people than ever in the South are waiting for cancer treatment, as waiting lists reach lengths never before experienced. ....

Bob King , Southern District Health Board , Cancer Society , Lyndell Kelly , Otago Daily Times , பாப் கிங் , தெற்கு மாவட்டம் ஆரோக்கியம் பலகை , புற்றுநோய் சமூகம் , லிண்டெல் கெல்லி , ஆடாகொ தினசரி முறை , அனுபவம் வாய்ந்த ,

Welcome To IANS Live - LatestNews - IIT Mandi invents new technique to detect abnormal brain activity

Photo Credit: IANS
IANSLive
Mandi (Himachal Pradesh), May 3 (IANS) Researchers at the Indian Institute of Technology (IIT) Mandi have invented a method to simultaneously study the variations in nerve functions and brain blood flow associated with brain disorders such as ischemic stroke.
To get full access of the story, click here to subscribe to IANS News Service
© 2021 IANS India Private Limited. All Rights Reserved.
The reproduction of the story/photograph in any form will be liable for legal action.
For news, views and gossips, follow IANS at Twitter.
Update: 03-May-2021 ....

Mandi Himachal Pradesh , India Private , Indian Institute Of Technology , News Service , Himachal Pradesh , Indian Institute , All Rights , Area The , மண்டி இமாச்சல் பிரதேஷ் , இந்தியா ப்ரைவேட் , இந்தியன் நிறுவனம் ஆஃப் தொழில்நுட்பம் , செய்தி சேவை , இமாச்சல் பிரதேஷ் , இந்தியன் நிறுவனம் , அனைத்தும் உரிமைகள் , பரப்பளவு தி ,

Natco Pharma gets emergency nod for Baricitinib tablets to treat Covid-19

May 03, 2021
Baricitinib in combination with Remdesivir, is used for treatment of Covid positive patients.
Natco Pharma Limited has received Emergency Use approval for Baricitinib tablets from Central Drugs Standard Control Organization (CDSCO) in India.
Baricitinib in combination with Remdesivir, is used for treatment of Covid-19 positive patients.
Hyderabad-based Natco will be requesting a Compulsory License based on emergency use and in light of the grave and serious public health emergency across India due to the Pandemic.
The company is ready to launch the product this week, so as to make it available to suffering patients across India, the release added. ....

Central Drugs Standard Control Organization , Natco Pharma , Natco Pharma Limited , Emergency Use , Compulsory License , Emergency Nod , Baricitinib Tablets , Covid 19 , மைய மருந்துகள் தரநிலை கட்டுப்பாடு ஆர்கநைஸேஶந் , நாட்கோ பார்மா , நாட்கோ பார்மா வரையறுக்கப்பட்டவை , அவசரம் பயன்பாடு , கட்டாய உரிமம் , அவசரம் இல்லை ,

Welcome To IANS Live - SCIENCE - IIT Mandi invents new technique to detect abnormal brain activity

Photo Credit: IANS
IANSLive
Mandi (Himachal Pradesh), May 3 (IANS) Researchers at the Indian Institute of Technology (IIT) Mandi have invented a method to simultaneously study the variations in nerve functions and brain blood flow associated with brain disorders such as ischemic stroke.
To get full access of the story, click here to subscribe to IANS News Service
© 2021 IANS India Private Limited. All Rights Reserved.
The reproduction of the story/photograph in any form will be liable for legal action.
For news, views and gossips, follow IANS at Twitter.
Update: 03-May-2021 ....

Mandi Himachal Pradesh , India Private , Indian Institute Of Technology , News Service , Himachal Pradesh , Indian Institute , All Rights , Area The , மண்டி இமாச்சல் பிரதேஷ் , இந்தியா ப்ரைவேட் , இந்தியன் நிறுவனம் ஆஃப் தொழில்நுட்பம் , செய்தி சேவை , இமாச்சல் பிரதேஷ் , இந்தியன் நிறுவனம் , அனைத்தும் உரிமைகள் , பரப்பளவு தி ,

MDMA Reaches Next Step Toward Approval for Treatment

May 3, 2021Updated 6:55 p.m. ET
In an important step toward medical approval, MDMA, the illegal drug popularly known as Ecstasy or Molly, was shown to bring relief to those suffering from severe post-traumatic stress disorder when paired with talk therapy.
Of the 90 people who took part in the new study, which is expected to be published later this month in Nature Medicine, those who received MDMA during therapy experienced a significantly greater reduction in the severity of their symptoms compared with those who received therapy and an inactive placebo. Two months after treatment, 67 percent of participants in the MDMA group no longer qualified for a diagnosis of PTSD, compared with 32 percent in the placebo group. ....

New York , United States , San Francisco , Jennifer Mitchell , Gul Dolen , Scott Ostrom , Rick Doblin , Alexander Shulgin , Jamie Ehrenkranz , Allen James Frances , Anastasiia Sapon , Nathan Mcgee , Leo Zeff , Albert Garcia Romeu , University Of California , Multidisciplinary Association For Psychedelic , Drug Enforcement Administration , Mental Health Services Administration , Drug Administration , Johns Hopkins University School Of Medicine , New York Times , Us Department Of Veterans Affairs , Duke University , Nature Medicine , Johns Hopkins University School , James Frances ,